4.5 Article

HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study

期刊

LANCET HIV
卷 8, 期 7, 页码 E420-E428

出版社

ELSEVIER INC
DOI: 10.1016/S2352-3018(21)00005-9

关键词

-

资金

  1. France Recherche Nord & Sud Sidahiv Hepatites (ANRS) [12369]
  2. Expertise France Initiative 5%
  3. ANRS [12324B99]

向作者/读者索取更多资源

The study on HIV pre-exposure prophylaxis (PrEP) in men who have sex with men (MSM) in West Africa showed that PrEP could effectively prevent HIV infection without increasing risky sexual behaviors or other sexually transmitted infections. Urgent implementation of PrEP in West Africa is recommended, with special attention to retention in care and PrEP adherence to ensure its full prevention potential.
Background HIV pre-exposure prophylaxis (PrEP) data in men who have sex with men (MSM) in west Africa are essential to guide its large-scale implementation. We assessed the uptake of event-driven and daily PrEP, HIV incidence, and changes over time in sexual behaviours and prevalence of bacterial sexually transmitted infections (STIs) in MSM in Burkina Faso, Cote d'Ivoire, Mali, and Togo. Methods We did a prospective cohort study from Nov 20, 2017, to April 14, 2020, in four community-based clinics in Abidjan (Cote d'Ivoire), Bamako (Mali), Lome (Togo), and Ouagadougou (Burkina Faso). Participants were MSM aged 18 years or older at substantial risk of HIV infection. Participants could choose between event-driven (2+1+1 dosing) and daily oral PrEP (tenofovir disoproxil fumarate 300 mg plus emtricitabine 200 mg), switch regimen, and discontinue or restart PrEP. We compared HIV incidence in this study with that of the same cohort before the availability of PrEP (CohMSM). Statistical analysis included the Kaplan-Meier method and mixed-effects regression models. This study is registered with ClinicalTrials.gov, NCT03459157. Findings We followed up 598 participants for a total of 743 center dot 6 person-years. At enrolment, 445 (74%) of 598 participants chose event-driven PrEP and 153 (26%) of 598 chose daily PrEP. 60 (13%) of 445 and 65 (42%) of 153 partici pants switched PrEP regimen at least once (p<0 center dot 0001). 159 participants (27%) were lost to follow-up. Overall HIV incidence was 2 center dot 3 per 100 person-years (95% CI 1 center dot 3-3 center dot 7; adjusted incidence rate ratio 0 center dot 21, 95% CI 0 center dot 12-0 center dot 36 compared with CohMSM). Adherence was optimal in 802 (41%) of 1946 measures with event-driven PrEP and in 394 (71%) of 554 measures with daily PrEP (p<0 center dot 0001). Coverage of sex acts with PrEP only and PrEP and condom decreased during follow-up (p=0 center dot 039 if PrEP only; p=0 center dot 0025 if PrEP and condom). The frequency of condomless anal sex remained stable (p=0 center dot 96). The number of male sexual partners (p<0 center dot 0001) and number of sex acts with casual male partners (p=0 center dot 0014 for 1-4 sex acts in previous 4 weeks; p=0 center dot 030 for >= 5 sex acts) decreased. The prevalence of gonorrhoea, chlamydia, and syphilis remained stable. Interpretation PrEP availability helped prevent HIV infection and did not lead to an increase in risky sexual behaviours or other STIs. PrEP should be urgently implemented in west Africa. Retention in care and PrEP adherence require special attention to ensure PrEP reaches its full prevention potential. Funding ANRS and Expertise France. Copyright (c) 2021 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据